{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:52:36Z","timestamp":1787237556118,"version":"build-2736575974"},"reference-count":0,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CE"],"DOI":"10.2147\/ce.s6000","type":"journal-article","created":{"date-parts":[[2010,9,14]],"date-time":"2010-09-14T19:51:22Z","timestamp":1284493882000},"page":"159","source":"Crossref","is-referenced-by-count":13,"title":["Golimumab: A novel human anti-TNF-α monoclonal antibody for the treatment of rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis"],"prefix":"10.2147","author":[{"given":"Jonathan","family":"Kay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2009,7]]},"container-title":["Core Evidence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=5088","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,10,30]],"date-time":"2016-10-30T18:02:46Z","timestamp":1477850566000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.dovepress.com\/golimumab-a-novel-human-anti-tnf-alpha-monoclonal-antibody-for-the-tre-peer-reviewed-article-CE"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":0,"URL":"https:\/\/doi.org\/10.2147\/ce.s6000","relation":{},"ISSN":["1555-175X"],"issn-type":[{"value":"1555-175X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7]]}}}